Crystal structure of GSK3β in complex with the flavonoid, morin

Area of Science:

• Biochemistry
• Neuroscience
• Structural Biology

Background:

• Glycogen synthase kinase 3 beta (GSK3β) is a key kinase in cellular signaling.
• GSK3β hyperphosphorylates tau proteins, a hallmark of Alzheimer's disease (AD).
• Morin, a natural flavonoid, is a known GSK3β inhibitor with therapeutic potential for AD.

Purpose of the Study:

• To determine the crystal structure of GSK3β in complex with morin.
• To elucidate the inhibitory mechanism of morin on GSK3β.
• To explore morin's potential as a functional food and therapeutic scaffold for AD.

Main Methods:

• X-ray crystallography
• Biochemical assays
• Structural analysis

Main Results:

• The crystal structure of GSK3β in complex with morin was determined.
• Morin inhibits GSK3β by binding to the ATP binding pocket.
• This binding interaction provides a structural basis for morin's inhibitory activity.

Conclusions:

• Morin's inhibition of GSK3β offers a potential strategy for preventing AD.
• The determined structure provides insights for developing novel therapeutics based on the morin scaffold.
• Morin shows promise as a functional food ingredient for AD prevention.